Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the atopic dermatitis market size evolved in recent years?

The market for atopic dermatitis has experienced swift expansion in the past few years. It is projected to rise from $8.61 billion in 2024 to $9.96 billion in 2025, boasting a compound annual growth rate (CAGR) of 15.7%. Factors such as an increase in medical knowledge and awareness, higher incidence and prevalence rates, patient advocacy and support, the progression in treatment options, and research and development have contributed to the growth during the historic period.

What are the predictions for the atopic dermatitis market size in the coming years?

Expectations are high for a swift expansion in the atopic dermatitis market in the coming years. The market is projected to increase to $17.45 billion by 2029, with a compound annual growth rate (CAGR) of 15.0%. This growth over the forecast period can be attributed to advancements in biologic therapies, immunomodulators, small molecule drugs, as well as pediatric-specific treatments, gene therapy, and precision medicine. The integration of digital health is also a contributing factor. Major trends anticipated during the forecast period encompass advancements in topical technology, a concentrated focus on pediatric ad care, management of environmental allergens, and tools for precision diagnosis.

Get your atopic dermatitis market report here!

https://www.thebusinessresearchcompany.com/report/atopic-dermatitis-global-market-report

What key factors are fueling the growth of the atopic dermatitis market?

The escalating global incidence of atopic dermatitis is anticipated to significantly contribute to the expansion of the atopic dermatitis market. Atopic dermatitis, alternatively referred to as eczema, is a dermatological disorder characterized by skin dryness and itching. The rising occurrence of this condition necessitates more disease diagnosis and treatment. As per research put forth by Oxford Academic, a publishing corporation based in the UK, atopic dermatitis (AD) is extensively widespread worldwide, impacting about 2.6% of the total global population, translating into roughly 204 million people in 2024. This percentage encompasses around 101 million grown-up individuals and 103 million children. Consequently, the escalating incidence of atopic dermatitis is fueling the growth of the atopic dermatitis market.

How is the global atopic dermatitis market divided into key segments?

The atopic dermatitis market covered in this report is segmented –

1) By Drug Class: Corticosteroids, Emollients Or Moisturizers, IL-4 And PDE4 Inhibitors, Calcineurin Inhibitors, Antibiotics, Other Drug Classes

2) By Mode of Administration: Topical, Injectable, Oral

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids

2) By Emollients Or Moisturizers: Creams and Lotions, Ointments and Balms, Barrier Repair Creams

3) By IL-4 And PDE4 Inhibitors: Dupilumab (IL-4 Inhibitor), Apremilast (PDE4 Inhibitor)

4) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream

5) By Antibiotics: Topical Antibiotics, Systemic Antibiotics

6) By Other Drug Classes: Antihistamines, Biologics, JAK Inhibitors

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8285&type=smp

Who are the key firms paving the way for growth in the atopic dermatitis market?

Major companies operating in the atopic dermatitis market are Sanofi SA, Meda AB, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, F Hoffmann-La Roche AG, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Mylan MV, Allergan PLC, Encore Dermatology Inc., Menlo Therapeutics Inc., Johnson & Johnson, Merck & Co Inc., Roche Holding AG, Valeant Pharmaceuticals International Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eisai Co. Ltd., Gilead Sciences Inc., Ipsen Biopharmaceuticals Inc., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Limited

Which trends are expected to transform the atopic dermatitis market?

Emerging trends in the atopic dermatitis market are largely centered on product innovation. Leading companies are focusing on the introduction of novel products to enhance their market standing. A case in point is the FDA approval received by Regeneron Pharmaceuticals Inc., a biotech firm based in the United States, for Dupixent (dupilumab) in June 2022. The drug, Dupixent, is designed for use by children aged between 6 months and 5 years suffering from moderate-to-severe atopic dermatitis and can be used in conjunction or individually with topical corticosteroids. The mechanism of Dupixent involves the suppression of signals from two primary Type 2 inflammatory sources (IL-4 and IL-13), these are integral to the onset of eosinophilic esophagitis, prurigo nodularis, chronic rhinosinusitis with nasal polyposis, and asthma.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8285

What regions are contributing significantly to the growth of the atopic dermatitis market?

North America was the largest region in the atopic dermatitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atopic dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Dermatology Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Dermatology Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dermatology-devices-global-market-report

Dermatology Medical Lasers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dermatology-medical-lasers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: